EcoDrugPlus

Protein Kinase C Delta

Ensembl ID : ENSCPOG00000011547
Gene Symbol: PRKCD
2 Cross references
283 Possible Orthologues:

Protein Kinase C Epsilon

Ensembl ID : ENSCPOG00000024627
Gene Symbol: PRKCE
4 Cross references
328 Possible Orthologues:

Protein Kinase C Eta

Ensembl ID : ENSCPOG00000009643
Gene Symbol: PRKCH
2 Cross references
241 Possible Orthologues:

Protein Kinase C Gamma

Ensembl ID : ENSCPOG00000024127
Gene Symbol: PRKCG
4 Cross references
200 Possible Orthologues:

Protein Kinase C Iota

Ensembl ID : ENSCPOG00000015212
Gene Symbol: PRKCI
2 Cross references
225 Possible Orthologues:

Protein Kinase C Theta

Ensembl ID : ENSCPOG00000014866
Gene Symbol: PRKCQ
4 Cross references
204 Possible Orthologues:

Protein Kinase C Zeta

Ensembl ID : ENSCPOG00000013852
Gene Symbol: PRKCZ
2 Cross references
201 Possible Orthologues:

Protein Kinase D1

Ensembl ID : ENSCPOG00000004855
Gene Symbol: PRKD1
2 Cross references
214 Possible Orthologues:

Protein Kinase D3

Ensembl ID : ENSCPOG00000012206
Gene Symbol: PRKD3
4 Cross references
274 Possible Orthologues:

Protein Kinase Camp-Activated Catalytic Subunit Beta

Ensembl ID : ENSCPOG00000036250
Gene Symbol: PRKACB
4 Cross references
304 Possible Orthologues:

Protein Kinase, Dna-Activated, Catalytic Subunit

Ensembl ID : ENSCPOG00000013944
Gene Symbol: PRKDC
2 Cross references
187 Possible Orthologues:

Protein Phosphatase 3 Catalytic Subunit Alpha

Ensembl ID : ENSCPOG00000009843
Gene Symbol: PPP3CA
4 Cross references
232 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).